Immune modulation of minimal residual disease in early chronic phase chronic myelogenous leukemia: a randomized trial of frontline high-dose imatinib mesylate with or without pegylated interferon alpha-2b and granulocyte-macrophage colony-stimulatin
| Image |  |
|---|---|
| Description | scientific article |
| Author/s |
author: Susan O'Brien Guillermo Garcia-Manero Srdan Verstovsek Jorge Eduardo Cortes Hagop Kantarjian Jenny Pui Shan Wong Farhad Ravandi |
| Publication date | September 30, 2010 |
| Language | English |
| Country of origin | |
| Wikipedia link | |
| Copyright status | |
| Missing/wrong data? | Edit Wikidata item |